LUMOS PHARMA, INC. Quarterly Nonoperating Income (Expense) in USD from Q1 2016 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Lumos Pharma, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2016 to Q3 2024.
  • Lumos Pharma, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $173K, a 72.6% decline year-over-year.
  • Lumos Pharma, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $1.41M, a 45.2% decline year-over-year.
  • Lumos Pharma, Inc. annual Nonoperating Income (Expense) for 2023 was $2.55M, a 164% increase from 2022.
  • Lumos Pharma, Inc. annual Nonoperating Income (Expense) for 2022 was $965K, a 243% increase from 2021.
  • Lumos Pharma, Inc. annual Nonoperating Income (Expense) for 2021 was $281K, a 95.8% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $1.41M $173K -$459K -72.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $1.87M $272K -$411K -60.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-02
Q1 2024 $2.28M $421K -$268K -38.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $2.55M $547K -$28K -4.87% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 $2.58M $632K +$333K +111% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $2.25M $683K +$603K +754% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-02
Q1 2023 $1.64M $689K +$678K +6164% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $965K $575K +$283K +96.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 $682K $299K +$290K +3222% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $392K $80K +$86K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $306K $11K +$25K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 $281K $292K +$305K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-07
Q3 2021 -$24K $9K -$6.48M -99.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $6.46M -$6K -$104K -106% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $6.56M -$14K -$106K -115% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 $6.67M -$13K -$36K -157% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-11
Q3 2020 $6.7M $6.49M +$6.46M +22279% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $242K $98K +$72K +277% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $170K $92K +$59K +179% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $111K $23K -$377K -94.3% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-09
Q3 2019 $488K $29K -$615K -95.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $1.1M $26K -$409K -94% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 $1.51M $33K -$363K -91.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-02
Q4 2018 $1.88M $400K +$165K +70.2% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-03
Q3 2018 $1.71M $644K +$484K +303% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $1.23M $435K +$434K +43400% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $792K $396K +$421K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $371K $235K +$106K +82.2% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-03
Q3 2017 $265K $160K +$141K +742% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-02
Q2 2017 $124K $1K -$59K -98.3% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-06
Q1 2017 $183K -$25K -$64K -164% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $247K $129K Oct 1, 2016 Dec 31, 2016 10-K 2019-03-05
Q3 2016 $19K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-03
Q2 2016 $60K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 $39K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.